Db. Gough et al., PSEUDOMYXOMA PERITONEI - LONG-TERM PATIENT SURVIVAL WITH AN AGGRESSIVE REGIONAL APPROACH, Annals of surgery, 219(2), 1994, pp. 112-119
Objective The aims of this study were to analyze the natural history o
f patients with pseudomyxoma peritonei (PMP), evaluate clinical and pa
thologic variables as prognostic indicators, and review the authors' e
xperience with different treatments. Summary Background Data PMP is an
unusual form of intra-abdominal neoplasm that presents with large amo
unts of extracellular mucin. Diffuse peritoneal spread occurs in most
patients with PMP, and distant metastasis is infrequent. Debulking sur
gery, radiation therapy (radioisotope and external beam), and chemothe
rapy (both intraperitoneal and systemic) have all been advocated for o
ptional patient management, but the variability of patients studied, t
he small patient numbers, and the prolonged course of this disease mak
e the evaluation of results difficult. Methods Fifty-six patients were
treated for PMP at the Mayo Clinic between 1957 and 1983. The data we
re collected retrospectively. Univariate (log-rank test) and multivari
ate (Cox regression model) analyses were performed for disease recurre
nce and patient survival. Results Most patients with PMP had carcinoma
s of the appendix (52%) or ovary (34%). All gross tumor could be remov
ed only in the 34% of patients with limited disease. Although tumor pr
ogression occurred in 76% of patients, the 1-, 5-, and 10-year surviva
l rates were 98%, 53%, and 32%, respectively. Adverse predictors of pa
tient survival included weight loss (p = 0.001), abdominal distention
(p = 0.004), use of systemic chemotherapy (p = 0.005), diffuse disease
(p = 0.038), and invasion of other organs (p = 0.04). Intraperitoneal
chemotherapy (p = 0.009) and radioisotopes (p = 0.0043) both were eff
ective in prolonging the recurrence time of symptomatic PMP. Conclusio
ns Although PMP is an indolent disease, aggressive surgical debulking
followed by intraperitoneal radioisotopes and/or chemotherapy should b
e considered because of the diffuse peritoneal involvement.